TGFB1 and melanoma: On the other hand, Li et al. demonstrated that the blockade of BRAF inhibitor-induced autophagy–lysosome activation in melanoma xenografts results in chemoresistance, which is associated with elevated TGF-β levels and enhanced TGF-β signaling [50].